QQCWB

GV

Seagen Company Profile: Valuation, Investors, Acquisition

Di: Ava

Pfizer’s $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See why I rate PFE stock a Buy. Information on acquisition, funding, investors, and executives for Swagelok. Use the PitchBook Platform to explore the full profile.

Information on valuation, funding, cap tables, investors, and executives for Iksuda Therapeutics. Use the PitchBook Platform to explore the full profile. Investor Relations NYSE: PFE 25.88 +0.14 (0.54%) 20 minutes minimum delay | Aug 22, 2025 4:00 PM 07.25.2025

Seagen logo hi-res stock photography and images - Alamy

Pfizer Inc. agreed to acquire cancer treatment company Seagen Inc. for $43 billion as it looks to incorporate cancer treatments into Seagen is set to be acquired by the large-cap pharma company, Pfizer, at a valuation of $43 billion. The stock is up about 15% in response to the news.

Advancing Oncology Innovation: Celebrating One Year of Pfizer + Seagen

Information on acquisition, funding, cap tables, investors, and executives for Imara. Use the PitchBook Platform to explore the full profile. Information on acquisition, funding, cap tables, investors, and executives for Allozyne. Use the PitchBook Platform to explore the full profile. Information on acquisition, funding, investors, and executives for SG Analytics. Use the PitchBook Platform to explore the full profile.

Information on valuation, funding, cap tables, investors, and executives for Seaweed Generation. Use the PitchBook Platform to explore the full profile. Pfizer is one of the largest pharmaceutical companies in the world. Many people often ask who owns Pfizer, as it plays a major role in healthcare and medicine worldwide. The

Information on acquisition, funding, investors, and executives for Tabuk Pharmaceuticals. Use the PitchBook Platform to explore the full profile. Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfizer’s position as a The Seagen Acquisition: A Pipeline Revolution In December 2023, Pfizer completed its $43 billion acquisition of Seagen, a move that

Monday, March 13, 2023 – 06:45am Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Information on acquisition, funding, cap tables, investors, and executives for CymaBay Therapeutics. Use the PitchBook Platform to explore the full profile.

  • Pfizer’s $43B buyout of ADC specialist Seagen is a done deal
  • Pfizer Completes Acquisition of Seagen
  • Seagen Set to be Acquired by Pfizer for $43 B, Stock Up

See Seagen funding rounds, investors, investments, exits and more. Evaluate their financials based on Seagen’s post-money valuation and revenue.

Seagen is a clinical-stage biotechnology company dedicated to improving patient outcomes with advanced antibody-drug conjugate technology. Information on valuation, funding, acquisitions, investors, and executives for Sagen MI Canada. Use the PitchBook Platform to explore the full profile. NEW YORK, December 14, 2023 – Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN), a global biotechnology

Information on acquisition, funding, investors, and executives for Modibodi. Use the PitchBook Platform to explore the full profile. Information on acquisition, funding, cap tables, investors, and executives for SoftEye. Use the PitchBook Platform to explore the full profile.

Shares of Seagen (SGEN) popped 14% yesterday on news that Pfizer (PFE) would acquire the company for $43 billion. The deal values Seagen shares at $229 and 15% Information on acquisition, funding, investors, and executives for Coverys. Use the PitchBook Platform to explore the full profile. Information on acquisition, funding, cap tables, investors, and executives for Juno Therapeutics. Use the PitchBook Platform to explore the full profile.

Information on acquisition, funding, investors, and executives for Blair. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Genmab. Use the PitchBook Platform to explore the full profile.

Information on acquisition, funding, investors, and executives for Endocyte. Use the PitchBook Platform to explore the full profile. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. “Cancer

Considering the hefty price tag on the most recent Pfizer acquisition deal, pharmaceutical industry leaders may benefit from a closer look at Seagen and why it’s appealing.

One year ago, Pfizer’s acquisition of Seagen Inc., one of the largest investments in Pfizer’s history, marked a bold step in the company’s plans to “Outdo” cancer, bringing together Changed name from Seattle Genetics, Oct. 9, 2020. Market value as of March 31, 2021. Seagen has acquired 1 company of its own. Seagen’s largest acquisition to date was in 2018, when it acquired Cascadian Therapeutics for $614M. Seagen has acquired in 1 US state. The

Information on acquisition, funding, cap tables, investors, and executives for Infinity Pharmaceuticals. Use the PitchBook Platform to explore the full profile.

Pfizer Inc on Monday struck a $43 billion deal to acquire Seagen Inc and its targeted cancer therapies as it braces for a steep fall in COVID-19 sales and generic Information on valuation, funding, cap tables, investors, and executives for Abacus Bioscience. Use the PitchBook Platform to explore the full profile.

Information on acquisition, funding, investors, and executives for NVM Pet. Use the PitchBook Platform to explore the full profile. Information on valuation, funding, cap tables, investors, and executives for Angiex. Use the PitchBook Platform to explore the full profile.